semaglutide 2024 Postpartum prescription of #GLP-1RAs in Denmark increased between 2018 and 2024, with #semaglutide accounting for most prescriptions since 2023. Most prescribed for #obesity, as only 23% had a #diabetes diagnosis, suggesting #WeightLoss Novo Nordisk takes legal action

Article PubMed Google Scholar Aronne, L

Department of Justice filed a complaint for permanent injunction on the FDAs behalf, citing Flawless Beauty for selling unapproved and mislabeled drugs (including products without FDA approval that were labeled FDA approved) that pose serious health risks, in particular the skin-whitening injectables that contain glutathione

Orforglipron does not directly displace these agents but rather complements them by offering an oral alternative for patients who prefer pills or do not require maximal weight loss

Ophthalmology 132 (4), 381388

J Neurochem 66: 15321538, 1996

Side effects No side effects are observed when taken in the recommended daily intake